Moderna
MRNA
#1213
Rank
โ‚น1.805 T
Marketcap
โ‚น4,551
Share price
0.27%
Change (1 day)
88.57%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น280.77 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2025 the company made an earning of -โ‚น262.95 Billion, an increase over its 2024 earnings that were of -โ‚น341.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น280.77 Billion6.78%
2025 -โ‚น262.95 Billion-23.03%
2024 -โ‚น341.61 Billion-8.22%
2023 -โ‚น372.21 Billion-140.65%
2022 โ‚น915.64 B-27.81%
2021 โ‚น1.268 T-1911.15%
2020 -โ‚น70.03 Billion44.7%
2019 -โ‚น48.4 Billion28.63%
2018 -โ‚น37.63 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.476 T-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.504 T-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น1.253 T-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.53 Billion-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.22 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.99 Billion-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.91 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น32.90 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA